Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

money maze payment reimbursement

Imaging advocacy group slams ‘extremely restrictive’ Medicare coverage determination

A Medicare Administrative Contractor is wrongly rejecting coverage of PET imaging in cases of infection/inflammation, SNMMI reported recently. 

prostate cancer PSA

FDA approves new PSMA-targeted PET imaging agent for prostate cancer

Blue Earth Diagnostics said this is the first and only PSMA-targeted imaging agent developed with its proprietary radiohybrid technology.

Thumbnail

Integra poised to take $60 million hit following voluntary recall of devices manufactured at Boston facility

Production of Integra’s SurgiMend, PriMatrix, Revize and TissueMend products has been temporarily halted due to the recalls, although the company said it has not received any customer complaints. 

Thumbnail

FDA approval of several impactful drugs could be delayed if US defaults on debt

The FDA’s process of reviewing and approving drugs and devices could be put on hold, if lawmakers fail to reach a deal related to the debt ceiling.

11 leading cardiology societies collaborate on new AUC for chronic coronary disease

The new AUC document, which examines the treatment of both symptomatic and asymptomatic patients, was published in full in the Journal of the American College of Cardiology.

Congress dome capitol Washington

American College of Radiology voices ‘enthusiastic support’ for bill to expand physician workforce

ACR joined 80 member organizations of the Graduate Medical Education Advocacy Coalition in urging Congress to pass a long sought-after proposal. 

biden administration artificial intelligence

White House spotlights 3 newly added items on AI to-do list

The Biden Administration has refreshed its efforts to encourage AI innovation while mitigating AI risks.

Federal Trade Commission issues warning to health companies about the misuse of consumer data

The new policy statement warns that any inaccurate or misleading claims to consumers about how their data is collected and used will be considered a violation of the FTC Act.